Current clinical utilization of risk assessment tools in pulmonary arterial hypertension: a descriptive survey of facilitation strategies, patterns, and barriers to use in the United States. (1st September 2020)
- Record Type:
- Journal Article
- Title:
- Current clinical utilization of risk assessment tools in pulmonary arterial hypertension: a descriptive survey of facilitation strategies, patterns, and barriers to use in the United States. (1st September 2020)
- Main Title:
- Current clinical utilization of risk assessment tools in pulmonary arterial hypertension: a descriptive survey of facilitation strategies, patterns, and barriers to use in the United States
- Authors:
- Wilson, Melisa
Keeley, Jennifer
Kingman, Martha
Wang, Jiajing
Rogers, Fran - Abstract:
- Abstract : Practice guidelines suggest that treatment decisions in pulmonary arterial hypertension be informed by periodic assessment of patients' clinical risk. Several tools, well validated for risk discrimination, such as the Registry to Evaluate Early and Long‐term Pulmonary Arterial Hypertension Disease Management calculator, were developed to assess pulmonary arterial hypertension patients' risk of death based on multiple parameters, including functional class, hemodynamics, biomarkers, comorbidities, and exercise capacity. Using an online survey, we investigated the use of risk assessment tools by pulmonary hypertension healthcare providers in the United States. Of 121 survey respondents who make treatment decisions, 59% reported using risk assessment tools. The use of these tools was lower for non‐physicians (48% vs. 65% physicians) and for practitioners at centers with 1 to 100 pulmonary arterial hypertension patients compared with centers with >100 patients (47% vs. 64%). Risk was most frequently assessed by decision makers at the time of diagnosis (cited by 54%) and at the time of worsening symptoms (cited by 42%), suggesting that use of pulmonary arterial hypertension risk assessment tools remains low. In our survey, non‐physicians compared with physicians cited two major barriers to increased tool use: lack of education and training (20% vs. 4%) and lack of clarity on the best tool to use (30% vs. 18%). Information technology tools, such as electronic medicalAbstract : Practice guidelines suggest that treatment decisions in pulmonary arterial hypertension be informed by periodic assessment of patients' clinical risk. Several tools, well validated for risk discrimination, such as the Registry to Evaluate Early and Long‐term Pulmonary Arterial Hypertension Disease Management calculator, were developed to assess pulmonary arterial hypertension patients' risk of death based on multiple parameters, including functional class, hemodynamics, biomarkers, comorbidities, and exercise capacity. Using an online survey, we investigated the use of risk assessment tools by pulmonary hypertension healthcare providers in the United States. Of 121 survey respondents who make treatment decisions, 59% reported using risk assessment tools. The use of these tools was lower for non‐physicians (48% vs. 65% physicians) and for practitioners at centers with 1 to 100 pulmonary arterial hypertension patients compared with centers with >100 patients (47% vs. 64%). Risk was most frequently assessed by decision makers at the time of diagnosis (cited by 54%) and at the time of worsening symptoms (cited by 42%), suggesting that use of pulmonary arterial hypertension risk assessment tools remains low. In our survey, non‐physicians compared with physicians cited two major barriers to increased tool use: lack of education and training (20% vs. 4%) and lack of clarity on the best tool to use (30% vs. 18%). Information technology tools, such as electronic medical record integration and web or phone‐based risk calculating applications, were cited most frequently as ways to increase the use of risk assessment tools. … (more)
- Is Part Of:
- Pulmonary circulation. Volume 10:Number 3(2020)
- Journal:
- Pulmonary circulation
- Issue:
- Volume 10:Number 3(2020)
- Issue Display:
- Volume 10, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 10
- Issue:
- 3
- Issue Sort Value:
- 2020-0010-0003-0000
- Page Start:
- 1
- Page End:
- 10
- Publication Date:
- 2020-09-01
- Subjects:
- mortality risk assessment -- multiparameter risk assessment -- pulmonary arterial hypertension -- REVEAL -- risk assessment tools
Pulmonary circulation -- Periodicals
Pulmonary circulation
Electronic journals -- Sciences
Periodicals
616.24005 - Journal URLs:
- http://www.jstor.org/action/showPublication?journalCode=pulmcirc ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1644 ↗
http://www.pulmonarycirculation.org/ ↗
https://uk.sagepub.com/en-gb/eur/pulmonary-circulation/journal202599 ↗
https://onlinelibrary.wiley.com/journal/20458940 ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1177/2045894020950186 ↗
- Languages:
- English
- ISSNs:
- 2045-8932
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26644.xml